Sems Lloyd 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Jun 16, 2022
Insider Transaction Report
Form 4
Sems Lloyd
Director
Transactions
- Award
Common Stock
2022-06-14+15,822→ 18,196 total - Award
Stock Option (right to buy)
2022-06-14+31,645→ 31,645 totalExercise: $1.11From: 2023-06-14Exp: 2032-06-14→ Common Stock (31,645 underlying)
Footnotes (2)
- [F1]The reporting person received an award of 15,822 restricted stock units on June 14, 2022, which shall vest in full on June 14, 2023.
- [F2]These options were granted to Mr. Sems for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.